Caerphilly Heart Disease Study

Last updated

The Caerphilly Heart Disease Study is an epidemiological prospective cohort. Caerphilly Heart Disease Study logo.jpg
The Caerphilly Heart Disease Study is an epidemiological prospective cohort.

The Caerphilly Heart Disease Study, also known as the Caerphilly Prospective Study (CaPS), is an epidemiological prospective cohort, set up in 1979 in a representative population sample drawn from Caerphilly, a typical small town in South Wales, UK. [1]

Contents

The initial aim was to examine relationships between a wide range of social, lifestyle, dietary and other factors with incident vascular disease. Opportunity was also taken, in collaboration with a range of clinical and laboratory colleagues, to collect data on a wide range of factors with possible relevance to diseases other than vascular, and at the same time to collect clinical information on incident disease events. The study was initiated by Professor Peter Elwood, Director of the Medical Research Council (MRC) Epidemiology Unit for South Wales. The work has so far led to over 400 publications in the medical press.

History

In 1948, an MRC epidemiological unit was set up in Cardiff, South Wales, under Professor Archie Cochrane. Peter Elwood joined Cochrane in 1963 and together they promoted long-term studies of representative population samples. They also conducted randomised controlled trials to test a variety of clinical hypotheses. Undoubtedly, the most important of their joint studies was a randomised controlled trial of aspirin showing a reduction of vascular mortality. [2]

Professor Peter Elwood and his team set up the Caerphilly Heart Disease Study in 1979. Prof Peter Elwood.jpg
Professor Peter Elwood and his team set up the Caerphilly Heart Disease Study in 1979.

Reported in the British Medical Journal in 1974, this was the first study to demonstrate a protective role for aspirin in the reduction of death and reinfarction. [3] The British Medical Journal recognised this article as one of the 50 most frequently cited papers published between 1945 and 1989. [4]

Following this trial, Elwood and his research team set up the Caerphilly Heart Disease Study, [1] with their primary focus on vascular disease, and the identification of predictors for platelet activity and thrombosis. Caerphilly was chosen for the work because the population was fairly stable, it had age and social class structures similar to that of the whole UK population, and there was a high incidence of ischaemic heart disease compared with the rest of the UK.

Study design

In 1979, all men aged between 45 and 59 years, who were on the electoral registers and/or general practice lists for Caerphilly and the adjoining villages of Abertridwr, Senghenydd, Trethomas, Bedwas and Machen were invited to co-operate in a long-term health study. 2,512 subjects (89% of the total eligible population) agreed to participate and were examined in Phase 1 (baseline) between July 1979 and September 1983. [1]

Since then, the men have been re-examined seven times (at five-year intervals) with approximately 95% of the surviving men co-operating in each re-examination. Many questions and tests have been repeated, but the opportunity has also been taken to include new questionnaires and tests. In the early phases of the study, samples of fasting blood were collected for extensive testing and long-term storage, and on occasions urine and other biological samples were also taken, and aliquots stored. Thus, while the initial aims of the study focused upon vascular disease, the wealth of data collected has enabled the testing of a large number of hypotheses relevant to other diseases too.[ citation needed ]

The Caerphilly Study research team, photographed outside the South Wales MRC Unit in Cardiff during the 1980s. Caerphilly Study research team.jpg
The Caerphilly Study research team, photographed outside the South Wales MRC Unit in Cardiff during the 1980s.

From the start of the study, the term 'Collaborative' was usually added to the title, paying tribute to the many physicians, laboratory technicians and other colleagues, expert in a wide range of clinical and metabolic disciplines, who were actively involved in the work.[ citation needed ]

Heart disease prevalence is far greater in men than women – therefore women were not included in the study. A far larger sample size would have been required if women had been the focus of the study, and unfortunately, the available resources were not sufficient for this.[ citation needed ]

The work in Caerphilly was often linked with the Speedwell Study, a similar study operating in nearby Bristol, 60 km away. The survey techniques were similar and a number of questionnaires and biological tests were used in both the studies. This enabled a number of joint reports on vascular disease, and in particular on the relevance of blood lipids, to be based on the five thousand subjects within the two cohorts together.

Funding

Initially, the study was funded by the Medical Research Council and led by Peter Elwood. Following Elwood's retirement in 1995 the study continued under the leadership of Dr John Gallacher (Cardiff University) and Professor Yoav Ben-Shlomo (Bristol University), together with Dr John Yarnell (Queen's University) and Professor Tony Bayer (Cardiff University). Financial support was obtained from the British Heart Foundation and the Alzheimer's Society.[ citation needed ]

Aims

The Caerphilly Study's research strategy was to identify factors showing an association with vascular disease (and other diseases), and then to test these associations in randomised controlled trials and statistical analysis.

The Framingham Heart Study, a much earlier cohort study in the US, had already shown that cholesterol is an important predictive factor for heart disease, [5] and studies of US Veterans had shown that raised blood pressure is a major factor in stroke. [6] The Caerphilly Study re-tested these predictors together with lipid fractions and high-density lipoproteins (total HDL, HDL2 and HDL3). [7] More recently, arterial resistance and its contribution to blood pressure has also been studied within the cohort. [8]

The Caerphilly Study's mobile research unit, parked in the grounds of Caerphilly District Miners' Hospital Caerphilly Heart Disease Study mobile unit.jpg
The Caerphilly Study's mobile research unit, parked in the grounds of Caerphilly District Miners' Hospital

The randomised controlled trial of aspirin had shown that blood platelets play a key role in vascular disease. [2] The Caerphilly Study focused on this by developing a large data-bank of platelet testing during the early phases of the study. Platelet collection and analysis was undertaken in close collaboration with Dr John O'Brien, Consultant Haematologist in St Mary's Hospital, Portsmouth, Professor Serge Renaud, a Director of Research in the French National Institute of Health and Medical Research in Lyon, and Professor Rod Flower FRS, then at the University of Bath. The work was done in a specially equipped mobile platelet laboratory, lent to the Caerphilly team by Serge Renaud, and towed by him from INSERM in Lyon, France, to the Miners' Hospital. [9]

Detailed work was also completed on thrombosis and haemostatic factors with the active involvement of John O'Brien and in collaboration with Professor Gordon Lowe, in the Institute of Cardiovascular and Medical Sciences. [10] [11] [12] [13] [14]

At baseline, a 1:3 sample (668 men) completed a 7-day weighed dietary intake record. Data on the dietary intake of each subject in the cohort was collected during each phase of the study.

Ten years into the study a detailed package of cognitive function tests were performed by each subject. These tests have been repeated several times [15] and later enabled the evaluation of factors with possible relevance to cognitive decline and dementia.

Major findings

Healthy lifestyles

The Caerphilly Study gave opportunity to study the relationship between lifestyle choices and health in a representative population sample drawn from a typical small town in the UK. [16] The participants were asked detailed questions at baseline and at subsequent examinations about lifestyle behaviours, enabling the men to be classified in terms of five healthy behaviours:

These healthy behaviours displayed significant negative associations with cognitive impairment and dementia, with participant disease outcomes falling as the number of healthy behaviours followed increased. Men who followed four or five of the healthy behaviours during 30 years of follow-up experienced on average a 73% reduction in diabetes, a 67% reduction in vascular disease, a 35% reduction in cancer (attributable to non-smoking alone) and a 64% reduction in cognitive impairment and dementia. [16]

Healthy behaviours are the responsibility of each individual, [17] and <1% of the men in the Caerphilly Study followed all five, with only 5% following four consistently. [16] Comparisons with data collected in the 2009 Welsh Health Survey indicate that while the pattern of behaviours has changed, the proportions of subjects following four or five of the healthy behaviours has scarcely altered over the past 30 years. [18]

The Caerphilly Study estimated the likely effect of increased healthy living within the community by supposing that each man in the Caerphilly cohort had each been urged at the start of the study in 1979 to adopt just one additional healthy behaviour. If only half of them had complied, then over the following 30 years 12% fewer would have developed diabetes; 6% fewer would have had a vascular disease event; 13% fewer would have developed dementia; and there would have been 5% fewer deaths. [16] A video summarising this work is available on YouTube. [19]

Cognitive function

Participants were asked to obtain from a close female relative the details of their own birth weight and how they had been fed as infants. Over half of the men obtained these details, and results showed that having been breast fed conferred some protection against the loss of cognitive function later in life, particularly in those whose birth weight had been low. [20]

Smoking, alcohol intake and leisure activities are lifestyle factors which were found to be predictive of cognitive function. [21] Significant associations were also between cognitive function and blood rheology and negative associations with both haematocrit and plasma viscosity, but not with the thrombotic potential of blood, as indicated by fibrinogen level. [22] These relationships appear to be direct, and not through underlying long-term disease processes. Sleep pattern, and in particular severe daytime sleepiness, was also predictive of vascular dementia. [23]

In diabetic subjects, it was found that poor control of blood sugar was associated with a lower cognitive function, and diabetes per se, but none of the components of metabolic syndrome, other than high blood pressure, were predictive of worse cognition. [24] Hearing loss was also found to be predictive of later cognitive impairment and incident dementia. [25]

Platelets and thrombosis

The main objective of the work on platelets was to identify an aspect of platelet morphology or activity with predictive power for incident vascular disease, which could be developed as a screening test to identify subjects at high risk of a vascular event. In addition to number and size of the platelets, three tests of platelet aggregation were performed, several being repeated after five years. A stressed template bleeding time test was also performed on each man.[ citation needed ]

No prediction for heart disease was shown by any aspect of platelet morphology nor any platelet test, nor by the bleeding time test. An unexpected finding was that the men who had had the most active platelets in two tests, based on platelet rich plasma and whole blood, had the lowest subsequent risk of an incident ischaemic stroke. [26]

Diet and dietary items

Detailed analyses of the dietary data identified a number of food items related to vascular disease risk. The consumption of fatty fish was associated with lower levels of blood lipids, [27] and a reduction in vascular disease mortality was confirmed in a randomised trial. [28]

Milk consumption was found to be associated with a small reduction in the metabolic syndrome, [29] and reductions in ischaemic heart disease, ischaemic stroke and diabetes, [30] and these findings were confirmed in later overviews and meta-analyses. [31] A reduction in blood pressure associated with milk consumption is well recognised, but new work in Caerphilly also identified a reduction in arterial stiffness associated with milk consumption. [8]

The consumption of fruit and vegetables was shown to be positively associated with blood antioxidant levels. [32] Detailed work with Serge Renaud on platelet activity showed a beneficial relationship between a low alcohol consumption and platelet aggregation, but an enhanced response to thrombin with binge drinking, confirming previous work in animals. [33]

Sleep

A detailed questionnaire of sleep pattern was included in one of the re-examinations of the men. In addition to the association with cognitive function already mentioned, [23] there was evidence of an increase in ischaemic stroke in men whose sleep is frequently disturbed, and an association between daytime sleepiness and a significant increase in ischaemic heart disease. [34]

Other studies

Many analyses of foods and dietary factors were conducted, as well as an examination of Helicobacter pylori and other infections, and vascular disease risk. [35] [36] [37] A reduction in vascular disease mortality was found in those subjects most sexually active. [38] Relationships between vascular disease and psychiatric symptoms, [39] [40] noise exposure, [41] [42] and hearing loss [25] were also identified.

Related Research Articles

<span class="mw-page-title-main">Dementia</span> Long-term brain disorders causing impaired memory, thinking and behavior

Dementia is a syndrome associated with many neurodegenerative diseases, characterized by a general decline in cognitive abilities that affects a person's ability to perform everyday activities. This typically involves problems with memory, thinking, behavior, and motor control. Aside from memory impairment and a disruption in thought patterns, the most common symptoms of dementia include emotional problems, difficulties with language, and decreased motivation. The symptoms may be described as occurring in a continuum over several stages. Dementia ultimately has a significant effect on the individual, their caregivers, and their social relationships in general. A diagnosis of dementia requires the observation of a change from a person's usual mental functioning and a greater cognitive decline than might be caused by the normal aging process.

<span class="mw-page-title-main">Vascular dementia</span> Dementia resulting from stroke

Vascular dementia is dementia caused by a series of strokes. Restricted blood flow due to strokes reduces oxygen and glucose delivery to the brain, causing cell injury and neurological deficits in the affected region. Subtypes of vascular dementia include subcortical vascular dementia, multi-infarct dementia, stroke-related dementia, and mixed dementia.

Archibald Leman Cochrane was a Scottish physician noted for his book, Effectiveness and Efficiency: Random Reflections on Health Services, which advocated the use of randomized controlled trials (RCTs) to improve clinical trials and medical interventions. His advocacy of RCTs eventually led to the creation of the Cochrane Library database of systematic reviews, the UK Cochrane Centre in Oxford and Cochrane, an international organization of review groups that are based at research institutions worldwide. He is known as one of the fathers of modern clinical epidemiology and is considered to be the originator of the idea of evidence-based medicine. The Archie Cochrane Archive is held at the Archie Cochrane Library at University Hospital Llandough, Penarth.

A cohort study is a particular form of longitudinal study that samples a cohort, performing a cross-section at intervals through time. It is a type of panel study where the individuals in the panel share a common characteristic.

<span class="mw-page-title-main">Trethomas</span> Human settlement in Wales

Trethomas is a small village 2+1⁄2 miles (4 km) northeast of Caerphilly, southeast Wales, situated in the Caerphilly county borough, within the historic boundaries of Monmouthshire.

Bedwas is a town situated two miles north-east of Caerphilly, south Wales, situated in the Caerphilly county borough, within the historic boundaries of Monmouthshire.

<span class="mw-page-title-main">Machen</span> Human settlement in Wales

Machen is a large village three miles east of Caerphilly, south Wales. It is situated in the Caerphilly borough within the historic boundaries of Monmouthshire. It neighbours Bedwas and Trethomas, and forms a council ward in conjunction with those communities. It lies on the Rhymney River. Mynydd Machen provides a view over the village. It is possible to walk up to and along the top of the mountain, where a number of large boulders are present.

<span class="mw-page-title-main">Framingham Heart Study</span> Cardiovascular cohort study

The Framingham Heart Study is a long-term, ongoing cardiovascular cohort study of residents of the city of Framingham, Massachusetts. The study began in 1948 with 5,209 adult subjects from Framingham, and is now on its third generation of participants. Prior to the study almost nothing was known about the epidemiology of hypertensive or arteriosclerotic cardiovascular disease. Much of the now-common knowledge concerning heart disease, such as the effects of diet, exercise, and common medications such as aspirin, is based on this longitudinal study. It is a project of the National Heart, Lung, and Blood Institute, in collaboration with Boston University. Various health professionals from the hospitals and universities of Greater Boston staff the project.

<span class="mw-page-title-main">Abertridwr, Caerphilly</span> Village in Wales

Abertridwr is a village in Caerphilly County Borough, Wales, situated about 3 miles (4.8 km) north-west of Caerphilly town. The "three waters" or "three streams" are Nant Cwm-parc, Nant Cwmceffyl and Nant Ilan, which join to form Nant yr Aber.

The Whitehall Studies investigated social determinants of health, specifically the cardiovascular disease prevalence and mortality rates among British civil servants. The initial prospective cohort study, the Whitehall I Study, examined over 17,500 male civil servants between the ages of 20 and 64, and was conducted over a period of ten years, beginning in 1967. A second cohort study, the Whitehall II Study, was conducted from 1985 to 1988 and examined the health of 10,308 civil servants aged 35 to 55, of whom two thirds were men and one third women. A long-term follow-up of study subjects from the first two phases is ongoing.

The prevention of dementia involves reducing the number of risk factors for the development of dementia, and is a global health priority needing a global response. Initiatives include the establishment of the International Research Network on Dementia Prevention (IRNDP) which aims to link researchers in this field globally, and the establishment of the Global Dementia Observatory a web-based data knowledge and exchange platform, which will collate and disseminate key dementia data from members states. Although there is no cure for dementia, it is well established that modifiable risk factors influence both the likelihood of developing dementia and the age at which it is developed. Dementia can be prevented by reducing the risk factors for vascular disease such as diabetes, high blood pressure, obesity, smoking, physical inactivity and depression. A study concluded that more than a third of dementia cases are theoretically preventable. Among older adults both an unfavorable lifestyle and high genetic risk are independently associated with higher dementia risk. A favorable lifestyle is associated with a lower dementia risk, regardless of genetic risk. In 2020, a study identified 12 modifiable lifestyle factors, and the early treatment of acquired hearing loss was estimated as the most significant of these factors, potentially preventing up to 9% of dementia cases.

<span class="mw-page-title-main">Leukoaraiosis</span> Type of white matter abnormality near the lateral ventricles

Leukoaraiosis is a particular abnormal change in appearance of white matter near the lateral ventricles. It is often seen in aged individuals, but sometimes in young adults. On MRI, leukoaraiosis changes appear as white matter hyperintensities (WMHs) in T2 FLAIR images. On CT scans, leukoaraiosis appears as hypodense periventricular white-matter lesions.

Sir Rory Edwards Collins FMedSci FRS is a British physician who is Professor of Medicine and Epidemiology at the Clinical Trial Service Unit within the University of Oxford, the head of the Nuffield Department of Population Health and a Fellow of Green Templeton College, Oxford. His work has been in the establishment of large-scale epidemiological studies of the causes, prevention and treatment of heart attacks, other vascular disease, and cancer, while also being closely involved in developing approaches to the combination of results from related studies ("meta-analyses"). Since September 2005, he has been the Principal Investigator and Chief Executive of the UK Biobank, a prospective study of 500,000 British people aged 40–69 at recruitment.

<span class="mw-page-title-main">Senghenydd</span> Human settlement in Wales

Senghenydd is a former mining village in the community of Aber Valley in South Wales, approximately four miles northwest of the town of Caerphilly. Historically within the county of Glamorgan, it is now situated in the county borough of Caerphilly. In the United Kingdom Census 2001, the population of the Aber Valley was 6,696. The wind farm proposed in 2023 would see the village surrounded by turbines up to 200 metres high.

Cognitive epidemiology is a field of research that examines the associations between intelligence test scores and health, more specifically morbidity and mortality. Typically, test scores are obtained at an early age, and compared to later morbidity and mortality. In addition to exploring and establishing these associations, cognitive epidemiology seeks to understand causal relationships between intelligence and health outcomes. Researchers in the field argue that intelligence measured at an early age is an important predictor of later health and mortality differences.

<span class="mw-page-title-main">Montreal Cognitive Assessment</span> Screening assessment for detecting cognitive impairment

The Montreal Cognitive Assessment (MoCA) is a widely used screening assessment for detecting cognitive impairment. It was created in 1996 by Ziad Nasreddine in Montreal, Quebec. It was validated in the setting of mild cognitive impairment (MCI), and has subsequently been adopted in numerous other clinical settings. This test consists of 30 points and takes 10 minutes for the individual to complete. The original English version is performed in seven steps, which may change in some countries dependent on education and culture. The basics of this test include short-term memory, executive function, attention, focus, and more.

<span class="mw-page-title-main">Early onset dementia</span> Cognitive disorder

Early onset dementia or young onset dementia refers to dementia with symptom onset prior to age 65. This condition is a significant public health concern, as the number of individuals with early onset dementia is increasing worldwide.

<span class="mw-page-title-main">Hypertension and the brain</span>

Hypertension is a condition characterized by an elevated blood pressure in which the long term consequences include cardiovascular disease, kidney disease, adrenal gland tumors, vision impairment, memory loss, metabolic syndrome, stroke and dementia. It affects nearly 1 in 2 Americans and remains as a contributing cause of death in the United States. There are many genetic and environmental factors involved with the development of hypertension including genetics, diet, and stress.

Peter Elwood is professor of epidemiology who for more than two decades led the Medical Research Council's Epidemiological Unit in South Wales. In 1979 he initiated the Caerphilly Heart Disease Study.

References

  1. 1 2 3 "Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group". Journal of Epidemiology and Community Health. 38 (3): 259–62. September 1984. doi:10.1136/jech.38.3.259. PMC   1052363 . PMID   6332166.
  2. 1 2 Elwood P (November 2006). "The first randomized trial of aspirin for heart attack and the advent of systematic overviews of trials". Journal of the Royal Society of Medicine. 99 (11): 586–8. doi:10.1177/014107680609901121. PMC   1633560 . PMID   17082305.
  3. ↑ Elwood PC, Cochrane AL, Burr ML, et al. (March 1974). "A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction". British Medical Journal. 1 (5905): 436–40. doi:10.1136/bmj.1.5905.436. PMC   1633246 . PMID   4593555.
  4. ↑ Dixon B (October 1990). "The 'top 50': a perspective on the BMJ drawn from the Science Citation Index". BMJ. 301 (6754): 747–51. doi:10.1136/bmj.301.6754.747. PMC   1664071 . PMID   2224253.
  5. ↑ Mahmood SS, Levy D, Vasan RS, Wang TJ (March 2014). "The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective". Lancet. 383 (9921): 999–1008. doi:10.1016/S0140-6736(13)61752-3. PMC   4159698 . PMID   24084292.
  6. ↑ Freis ED (1974). "The Veterans Administration cooperative study on antihypertensive agents. Implications for stroke prevention". Stroke. 5 (1): 76–7. doi: 10.1161/01.STR.5.1.76 . PMID   4811316.
  7. ↑ Sweetnam PM, Bolton CH, Yarnell JW, et al. (August 1994). "Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies". Circulation. 90 (2): 769–74. doi: 10.1161/01.CIR.90.2.769 . PMID   8044946.
  8. 1 2 Livingstone KM, Lovegrove JA, Cockcroft JR, Elwood PC, Pickering JE, Givens DI (January 2013). "Does dairy food intake predict arterial stiffness and blood pressure in men?: Evidence from the Caerphilly Prospective Study". Hypertension. 61 (1): 42–7. doi: 10.1161/HYPERTENSIONAHA.111.00026 . hdl: 10536/DRO/DU:30083001 . PMID   23150503.
  9. ↑ Elwood PC, Renaud S, Sharp DS, Beswick AD, O'Brien JR, Yarnell JW (January 1991). "Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study". Circulation. 83 (1): 38–44. doi: 10.1161/01.CIR.83.1.38 . PMID   1984896.
  10. ↑ Elwood PC, Renaud S, Beswick AD, O'Brien JR, Sweetnam PM (December 1998). "Platelet aggregation and incident ischaemic heart disease in the Caerphilly cohort". Heart. 80 (6): 578–82. doi:10.1136/hrt.80.6.578. PMC   1728885 . PMID   10065026.
  11. ↑ Lowe GD, Yarnell JW, Sweetnam PM, Rumley A, Thomas HF, Elwood PC (January 1998). "Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study". Thrombosis and Haemostasis. 79 (1): 129–33. doi:10.1055/s-0037-1614231. PMID   9459337. S2CID   21465449. Archived from the original on 1 September 2014.
  12. ↑ Rumley A, Lowe GD, Sweetnam PM, Yarnell JW, Ford RP (April 1999). "Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study". British Journal of Haematology. 105 (1): 110–6. doi: 10.1111/j.1365-2141.1999.01317.x . PMID   10233372.
  13. ↑ Yarnell JW, Sweetnam PM, Rumley A, Lowe GD (2001). "Lifestyle factors and coagulation activation markers: the Caerphilly study". Blood Coagulation and Fibrinolysis. 12 (8): 721–8. doi:10.1097/00001721-200112000-00015. PMID   11734674. S2CID   25136428.
  14. ↑ Lowe GD, Rumley A, Sweetnam PM, Yarnell JW, Rumley J (September 2001). "Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the caerphilly study". Thrombosis and Haemostasis. 86 (3): 822–7. doi:10.1055/s-0037-1616138. PMID   11583314. S2CID   18933540. Archived from the original on 1 September 2014.
  15. ↑ Fish M, Bayer AJ, Gallacher JE, et al. (2008). "Prevalence and pattern of cognitive impairment in a community cohort of men in South Wales: methodology and findings from the Caerphilly Prospective Study". Neuroepidemiology. 30 (1): 25–33. doi:10.1159/000115439. PMID   18259098. S2CID   6431973.
  16. 1 2 3 4 Elwood P, Galante J, Pickering J, et al. (2013). "Healthy lifestyles reduce the incidence of chronic diseases and dementia: evidence from the caerphilly cohort study". PLOS ONE. 8 (12): e81877. Bibcode:2013PLoSO...881877E. doi: 10.1371/journal.pone.0081877 . PMC   3857242 . PMID   24349147.
  17. ↑ Elwood P, Longley M (September 2010). "My health: whose responsibility? A jury decides". Journal of Epidemiology and Community Health. 64 (9): 761–4. doi:10.1136/jech.2009.087767. PMID   19897471. S2CID   21137383.
  18. ↑ Welsh Health Survey 2009, Welsh Government (2010)[ page needed ]
  19. ↑ ""How Healthy Lifestyles Reduce Our Risk of Chronic Diseases and Dementia" by Peter Elwood". www.youtube.com. 2014. Retrieved 24 November 2024.[ unreliable medical source? ]
  20. ↑ Elwood PC, Pickering J, Gallacher JE, Hughes J, Davies D (February 2005). "Long term effect of breast feeding: cognitive function in the Caerphilly cohort". Journal of Epidemiology and Community Health. 59 (2): 130–3. doi:10.1136/jech.2004.022913. PMC   1732991 . PMID   15650144.
  21. ↑ Elwood PC, Gallacher JE, Hopkinson CA, et al. (January 1999). "Smoking, drinking, and other life style factors and cognitive function in men in the Caerphilly cohort". Journal of Epidemiology and Community Health. 53 (1): 9–14. doi:10.1136/jech.53.1.9. PMC   1756770 . PMID   10326046.
  22. ↑ Elwood PC, Pickering J, Gallacher JE (March 2001). "Cognitive function and blood rheology: results from the Caerphilly cohort of older men". Age and Ageing. 30 (2): 135–9. doi: 10.1093/ageing/30.2.135 . PMID   11395343.
  23. 1 2 Elwood PC, Bayer AJ, Fish M, Pickering J, Mitchell C, Gallacher JE (September 2011). "Sleep disturbance and daytime sleepiness predict vascular dementia". Journal of Epidemiology and Community Health. 65 (9): 820–4. doi:10.1136/jech.2009.100503. PMID   20675705. S2CID   23995007.
  24. ↑ Gallacher JE, Pickering J, Elwood PC, Bayer AJ, Yarnell JW, Ben-Shlomo Y (2005). "Glucoregulation has greater impact on cognitive performance than macro-vascular disease in men with type 2 diabetes: data from the Caerphilly study". European Journal of Epidemiology. 20 (9): 761–8. doi:10.1007/s10654-005-2146-9. PMID   16170659. S2CID   20914461.
  25. 1 2 Gallacher J, Ilubaera V, Ben-Shlomo Y, et al. (October 2012). "Auditory threshold, phonologic demand, and incident dementia". Neurology. 79 (15): 1583–90. doi:10.1212/WNL.0b013e31826e263d. PMID   23019269. S2CID   207121920.
  26. ↑ Elwood PC, Beswick A, Pickering J, et al. (May 2001). "Platelet tests in the prediction of myocardial infarction and ischaemic stroke: evidence from the Caerphilly Prospective Study". British Journal of Haematology. 113 (2): 514–20. doi: 10.1046/j.1365-2141.2001.02728.x . PMID   11380425. S2CID   11906359.
  27. ↑ Fehily AM, Burr ML, Phillips KM, Deadman NM (September 1983). "The effect of fatty fish on plasma lipid and lipoprotein concentrations". The American Journal of Clinical Nutrition. 38 (3): 349–51. doi:10.1093/ajcn/38.3.349. PMID   6613908.
  28. ↑ Burr ML, Fehily AM, Gilbert JF, et al. (September 1989). "Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART)". Lancet. 2 (8666): 757–61. doi:10.1016/S0140-6736(89)90828-3. PMID   2571009. S2CID   36397342.
  29. ↑ Elwood PC, Pickering JE, Fehily AM (August 2007). "Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study". Journal of Epidemiology and Community Health. 61 (8): 695–8. doi:10.1136/jech.2006.053157. PMC   2652996 . PMID   17630368.
  30. ↑ Elwood PC, Pickering JE, Fehily AM, Hughes J, Ness AR (May 2004). "Milk drinking, ischaemic heart disease and ischaemic stroke I. Evidence from the Caerphilly cohort". European Journal of Clinical Nutrition. 58 (5): 711–7. doi:10.1038/sj.ejcn.1601868. PMID   15116073. S2CID   20028649.
  31. ↑ Elwood PC, Pickering JE, Givens DI, Gallacher JE (October 2010). "The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence". Lipids. 45 (10): 925–39. doi:10.1007/s11745-010-3412-5. PMC   2950929 . PMID   20397059.
  32. ↑ Strain JJ, Elwood PC, Davis A, et al. (November 2000). "Frequency of fruit and vegetable consumption and blood antioxidants in the Caerphilly cohort of older men". European Journal of Clinical Nutrition. 54 (11): 828–33. doi:10.1038/sj.ejcn.1601101. PMID   11114676. S2CID   23333509.
  33. ↑ Renaud SC, Ruf JC (March 1996). "Effects of alcohol on platelet functions". Clinica Chimica Acta. 246 (1–2): 77–89. doi:10.1016/0009-8981(96)06228-6. PMID   8814972.
  34. ↑ Elwood P, Hack M, Pickering J, Hughes J, Gallacher J (January 2006). "Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort". Journal of Epidemiology and Community Health. 60 (1): 69–73. doi:10.1136/jech.2005.039057. PMC   2465538 . PMID   16361457.
  35. ↑ Strachan DP, Mendall MA, Carrington D, et al. (September 1998). "Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the caerphilly prospective heart disease study". Circulation. 98 (13): 1286–90. doi: 10.1161/01.CIR.98.13.1286 . PMID   9751676.
  36. ↑ Strachan DP, Carrington D, Mendall M, Butland BK, Yarnell JW, Elwood P (February 2000). "Chlamydia pneumoniae serology, lung function decline, and treatment for respiratory disease". American Journal of Respiratory and Critical Care Medicine. 161 (2 Pt 1): 493–7. doi:10.1164/ajrccm.161.2.9904055. PMID   10673191.
  37. ↑ Strachan DP, Carrington D, Mendall MA, Butland BK, Sweetnam PM, Elwood PC (March 1999). "Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study". Heart. 81 (3): 248–51. doi:10.1136/hrt.81.3.248. PMC   1728973 . PMID   10026345.
  38. ↑ Ebrahim S, May M, Ben Shlomo Y, et al. (February 2002). "Sexual intercourse and risk of ischaemic stroke and coronary heart disease: the Caerphilly study". Journal of Epidemiology and Community Health. 56 (2): 99–102. doi:10.1136/jech.56.2.99. PMC   1732071 . PMID   11812807.
  39. ↑ Stansfeld SA, Sharp DS, Gallacher JE, Yarnell JW (November 1992). "A population survey of ischaemic heart disease and minor psychiatric disorder in men". Psychological Medicine. 22 (4): 939–49. doi:10.1017/s0033291700038514. PMID   1488489. S2CID   13284336.
  40. ↑ May M, McCarron P, Stansfeld S, et al. (January 2002). "Does psychological distress predict the risk of ischemic stroke and transient ischemic attack? The Caerphilly Study". Stroke: A Journal of Cerebral Circulation. 33 (1): 7–12. doi: 10.1161/hs0102.100529 . PMID   11779881.
  41. ↑ Stansfeld S, Gallacher J, Babisch W, Shipley M (August 1996). "Road traffic noise and psychiatric disorder: prospective findings from the Caerphilly Study". BMJ. 313 (7052): 266–7. doi:10.1136/bmj.313.7052.266. PMC   2351704 . PMID   8704537.
  42. ↑ Babisch W, Ising H, Elwood PC, Sharp DS, Bainton D (1993). "Traffic noise and cardiovascular risk: the Caerphilly and Speedwell studies, second phase. Risk estimation, prevalence, and incidence of ischemic heart disease". Archives of Environmental Health. 48 (6): 406–13. doi:10.1080/00039896.1993.10545962. PMID   8250592.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.